| 000382 (2020) |
Ye Qiu ; Yuan-Bo Zhao ; Qiong Wang ; Jin-Yan Li ; Zhi-Jian Zhou ; Ce-Heng Liao ; Xing-Yi Ge | Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |
| 000993 (2020) |
Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine] | Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target |
| 000219 (2020) |
Samuel James Brake [Australie] ; Kathryn Barnsley [Australie] ; Wenying Lu [Australie] ; Kielan Darcy Mcalinden [Australie] ; Mathew Suji Eapen [Australie] ; Sukhwinder Singh Sohal [Australie] | Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). |
| 000783 (2020) |
Junyi Guo ; Zheng Huang ; Li Lin ; Jiagao Lv | Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. |
| 000002 (2020-04-15) |
Reinhold Kreutz [Allemagne] ; Engi Abd El-Hady Algharably [Allemagne] ; Michel Azizi [France] ; Piotr Dobrowolski [Pologne] ; Tomasz Guzik [Royaume-Uni] ; Andrzej Januszewicz [Pologne] ; Alexandre Persu [Belgique] ; Aleksander Prejbisz [Pologne] ; Thomas Günther Riemer [Allemagne] ; Ji-Guang Wang [République populaire de Chine] ; Michel Burnier [Suisse] | Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 |
| 000056 (2020) |
Paolo Verdecchia ; Gianpaolo Reboldi ; Claudio Cavallini ; Giovanni Mazzotta ; Fabio Angeli | [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. |
| 000218 (2020) |
Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis] | Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
| 000251 (2020) |
Shu-Ren Li [République populaire de Chine] ; Zi-Jian Tang [République populaire de Chine] ; Zai-Han Li [République populaire de Chine] ; Xuan Liu [République populaire de Chine] | Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV. |
| 000311 (2020) |
Marco Alifano [France] ; Pietro Alifano [Italie] ; Patricia Forgez [France] ; Antonio Iannelli [France] | Renin-angiotensin system at the heart of COVID-19 pandemic |
| 000312 (2020) |
Guido Iaccarino [Italie] ; Claudio Borghi [Italie] ; Arrigo F. G. Cicero [Italie] ; Claudio Ferri [Italie] ; Pietro Minuz [Italie] ; Maria Lorenza Muiesan [Italie] ; Paolo Mulatero [Italie] ; Giuseppe Mulè [Italie] ; Giacomo Pucci [Italie] ; Massimo Salvetti [Italie] ; Carmine Savoia [Italie] ; Leonardo Alberto Sechi [Italie] ; Massimo Volpe [Italie] ; Guido Grassi [Italie] | Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension |
| 000480 (2020) |
Allegra Battistoni ; Massimo Volpe | Might renin-angiotensin system blockers play a role in the COVID-19 pandemic? |
| 000509 (2020) |
Zaid Abassi [Israël] ; Suheir Assady [Israël] ; Emad E. Khoury [Israël] ; Samuel N. Heyman [Israël] | Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications. |
| 000540 (2020) |
Thorsten Kessler [Allemagne] ; Heribert Schunkert [Allemagne] | Inhibitors of the renin–angiotensin system and SARS-CoV-2 infection |
| 000870 (2020) |
Leo F. Buckley ; Judy W M. Cheng ; Akshay Desai | Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2. |
| 000A97 (2004) |
Swee Kee Wong [États-Unis] ; Wenhui Li ; Michael J. Moore ; Hyeryun Choe ; Michael Farzan | A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. |
| 000018 (2020) |
Zhengpin Wang [États-Unis] ; Xiaojiang Xu [États-Unis] | scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells. |
| 000152 (2020) |
Mengmeng Li [République populaire de Chine] ; Liang Chen [République populaire de Chine] ; Jingxiao Zhang [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] | The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. |
| 000263 (2020) |
Soeren Lukassen [Allemagne] ; Robert Lorenz Chua [Allemagne] ; Timo Trefzer [Allemagne] ; Nicolas C. Kahn [Allemagne] ; Marc A. Schneider [Allemagne] ; Thomas Muley [Allemagne] ; Hauke Winter [Allemagne] ; Michael Meister [Allemagne] ; Carmen Veith [Allemagne] ; Agnes W. Boots [Pays-Bas] ; Bianca P. Hennig [Allemagne] ; Michael Kreuter [Allemagne] ; Christian Conrad [Allemagne] ; Roland Eils [Allemagne] | SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. |
| 000264 (2020) |
Soeren Lukassen [Allemagne] ; Robert Lorenz Chua [Allemagne] ; Timo Trefzer [Allemagne] ; Nicolas C. Kahn [Allemagne] ; Marc A. Schneider [Allemagne] ; Thomas Muley [Allemagne] ; Hauke Winter [Allemagne] ; Michael Meister [Allemagne] ; Carmen Veith [Allemagne] ; Agnes W. Boots [Pays-Bas] ; Bianca P. Hennig [Allemagne] ; Michael Kreuter [Allemagne] ; Christian Conrad [Allemagne] ; Roland Eils [Allemagne] | SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. |
| 000290 (2020) |
Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela] | Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis |
| 000306 (2020) |
Lance Turtle [Royaume-Uni] | Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2. |
| 000447 (2020) |
Sepideh Paybast [Iran] ; Ali Emami [Iran] ; Mohsen Koosha [Iran] ; Fatemeh Baghalha [Iran] | Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know. |
| 000460 (2020) |
Yeshun Wu [République populaire de Chine] ; Xiaolin Xu [République populaire de Chine] ; Zijun Chen [République populaire de Chine] ; Jiahao Duan [République populaire de Chine] ; Kenji Hashimoto [Japon] ; Ling Yang [République populaire de Chine] ; Cunming Liu [République populaire de Chine] ; Chun Yang [République populaire de Chine] | Nervous system involvement after infection with COVID-19 and other coronaviruses |
| 000863 (2020) |
Ali A. Asadi-Pooya [Iran, États-Unis] ; Leila Simani [Iran] | Central nervous system manifestations of COVID-19: A systematic review |
| 000994 (2020) |
David Gurwitz [Israël] | Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. |
| 000A89 (2006) |
Zheng Fan [République populaire de Chine] ; Yue Zhuo ; Xinyu Tan ; Zhi Zhou ; Jiangang Yuan ; Boqin Qiang ; Jinghua Yan ; Xiaozhong Peng ; George F. Gao | SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system. |
| 000040 (2020) |
X. Wang [République populaire de Chine] ; Y Q Ding [République populaire de Chine] | [From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment]. |
| 000049 (2020) |
B. El Boussadani [Maroc] ; C. Benajiba [Maroc] ; A. Aajal [Maroc] ; A. Ait Brik [Maroc] ; O. Ammour [Maroc] ; J. El Hangouch [Maroc] ; O. Oussama [Maroc] ; B. Oussama [Maroc] ; N. Tahiri [Maroc] ; Z. Raissuni [Maroc] | [COVID-19 pandemia: Impact on the cariovascular system. Data of 1st April 2020]. |
| 000072 (2020) |
Sang Il Kim [Corée du Sud] ; Ji Yong Lee [Corée du Sud] | Walk-Through Screening Center for COVID-19: an Accessible and Efficient Screening System in a Pandemic Situation. |
| 000151 (2020) |
Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine] | The Science Underlying COVID-19: Implications for the Cardiovascular System. |
| 000177 (2020) |
Liang Chen [République populaire de Chine] ; Xiangjie Li [République populaire de Chine] ; Mingquan Chen [République populaire de Chine] ; Yi Feng [République populaire de Chine] ; Chenglong Xiong [République populaire de Chine] | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. |
| 000199 (2020) |
Jian Shang [États-Unis] ; Yushun Wan [États-Unis] ; Chang Liu [États-Unis] ; Boyd Yount [États-Unis] ; Kendra Gully [États-Unis] ; Yang Yang [États-Unis] ; Ashley Auerbach [États-Unis] ; Guiqing Peng [République populaire de Chine] ; Ralph Baric [États-Unis] ; Fang Li [États-Unis] | Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. |
| 000200 (2020) |
Yun Chen [République populaire de Chine] ; Yao Guo [République populaire de Chine] ; Yihang Pan [République populaire de Chine] ; Zhizhuang Joe Zhao [République populaire de Chine, États-Unis] | Structure analysis of the receptor binding of 2019-nCoV |
| 000202 (2020) |
Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan] | Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. |
| 000203 (2020) |
Jian Shang [États-Unis] ; Gang Ye [États-Unis] ; Ke Shi [États-Unis] ; Yushun Wan [États-Unis] ; Chuming Luo [États-Unis] ; Hideki Aihara [États-Unis] ; Qibin Geng [États-Unis] ; Ashley Auerbach [États-Unis] ; Fang Li [États-Unis] | Structural basis of receptor recognition by SARS-CoV-2. |
| 000204 (2020) |
Renhong Yan [République populaire de Chine] ; Yuanyuan Zhang [République populaire de Chine] ; Yaning Li [République populaire de Chine] ; Lu Xia [République populaire de Chine] ; Yingying Guo [République populaire de Chine] ; Qiang Zhou [République populaire de Chine] | Structural basis for the recognition of SARS-CoV-2 by full-length human
ACE2 |
| 000206 (2020) |
Qihui Wang [République populaire de Chine] ; Yanfang Zhang [République populaire de Chine] ; Lili Wu [République populaire de Chine] ; Sheng Niu [République populaire de Chine] ; Chunli Song [République populaire de Chine] ; Zengyuan Zhang [République populaire de Chine] ; Guangwen Lu [République populaire de Chine] ; Chengpeng Qiao [République populaire de Chine] ; Yu Hu [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Qisheng Wang [République populaire de Chine] ; Huan Zhou [République populaire de Chine] ; Jinghua Yan [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] | Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. |
| 000214 (2020) |
Junwen Luan [République populaire de Chine] ; Yue Lu [République populaire de Chine] ; Xiaolu Jin [République populaire de Chine] ; Leiliang Zhang [République populaire de Chine] | Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection |
| 000254 (2020) |
Di Mauro Gabriella ; Scavone Cristina ; Rafaniello Concetta ; Rossi Francesco ; Capuano Annalisa | SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment |
| 000282 (2020) |
Markus Hoffmann [Allemagne] ; Hannah Kleine-Weber [Allemagne] ; Simon Schroeder [Allemagne] ; Nadine Krüger [Allemagne] ; Tanja Herrler [Allemagne] ; Sandra Erichsen [Autriche] ; Tobias S. Schiergens [Allemagne] ; Georg Herrler [Allemagne] ; Nai-Huei Wu [Allemagne] ; Andreas Nitsche [Allemagne] ; Marcel A. Müller [Russie] ; Christian Drosten [Allemagne] ; Stefan Pöhlmann [Allemagne] | SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. |
| 000328 (2020) |
Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Rachel Graham [États-Unis] ; Ralph S. Baric [États-Unis] ; Fang Li [États-Unis] | Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. |
| 000393 (2020) |
Wen-Hsiang Chen [États-Unis] ; Peter J. Hotez [États-Unis] ; Maria Elena Bottazzi [États-Unis] | Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19. |
| 000612 (2020) |
Roujian Lu [République populaire de Chine] ; Xiang Zhao [République populaire de Chine] ; Juan Li [République populaire de Chine] ; Peihua Niu [République populaire de Chine] ; Bo Yang [République populaire de Chine] ; Honglong Wu [République populaire de Chine] ; Wenling Wang [République populaire de Chine] ; Hao Song [République populaire de Chine] ; Baoying Huang [République populaire de Chine] ; Na Zhu [République populaire de Chine] ; Yuhai Bi [République populaire de Chine] ; Xuejun Ma [République populaire de Chine] ; Faxian Zhan [République populaire de Chine] ; Liang Wang [République populaire de Chine] ; Tao Hu [République populaire de Chine] ; Hong Zhou [République populaire de Chine] ; Zhenhong Hu [République populaire de Chine] ; Weimin Zhou [République populaire de Chine] ; Li Zhao [République populaire de Chine] ; Jing Chen [République populaire de Chine] ; Yao Meng [République populaire de Chine] ; Ji Wang [République populaire de Chine] ; Yang Lin [République populaire de Chine] ; Jianying Yuan [République populaire de Chine] ; Zhihao Xie [République populaire de Chine] ; Jinmin Ma [République populaire de Chine] ; William J. Liu [République populaire de Chine] ; Dayan Wang [République populaire de Chine] ; Wenbo Xu [République populaire de Chine] ; Edward C. Holmes [Australie] ; George F. Gao [République populaire de Chine] ; Guizhen Wu [République populaire de Chine] ; Weijun Chen [République populaire de Chine] ; Weifeng Shi [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] | Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding |
| 000619 (2020) |
Michael Letko [États-Unis] ; Andrea Marzi [États-Unis] ; Vincent Munster [États-Unis] | Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. |
| 000657 (2020) |
Susanne Pfefferle [Allemagne] ; Svenja Reucher [Allemagne] ; Dominic Nörz [Allemagne] ; Marc Lütgehetmann [Allemagne] | Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system. |
| 000704 (2020) |
Yuanyuan Li [République populaire de Chine] ; Honggang Li [République populaire de Chine] ; Liquan Zhou [République populaire de Chine] | EZH2-mediated H3K27me3 inhibits ACE2 expression. |
| 000712 (2020) |
Ki Tae Kwon [Corée du Sud] ; Jae Hoon Ko [Corée du Sud] ; Heejun Shin [Corée du Sud] ; Minki Sung [Corée du Sud] ; Jin Yong Kim [Corée du Sud] | Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak. |
| 000859 (2020) |
Xu Wang [République populaire de Chine] ; Xiaoxi Zhang [République populaire de Chine] ; Jiangjiang He [République populaire de Chine] | Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China. |
| 000913 (2020) |
Andrew M. South [États-Unis] ; Debra I. Diz [États-Unis] ; Mark C. Chappell [États-Unis] | COVID-19, ACE2, and the cardiovascular consequences. |
| 000965 (2020) |
Justine R. Horne [Canada] ; Marie-Claude Vohl [Canada] | Biological plausibility for interactions between dietary fat, resveratrol, ACE2 and SARS-CoV illness severity. |
| 000A16 (2020) |
Rhian M. Touyz [Royaume-Uni] ; Hongliang Li [République populaire de Chine] ; Christian Delles [Royaume-Uni] | ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. |
| 000A31 (2020) |
Qiang Wang [République populaire de Chine] ; Qin Du [République populaire de Chine] ; Bin Guo [République populaire de Chine] ; Daiyong Mu [République populaire de Chine] ; Xiaolan Lu [République populaire de Chine] ; Qiang Ma [République populaire de Chine] ; Yangliu Guo [République populaire de Chine] ; Li Fang [République populaire de Chine] ; Bing Zhang [République populaire de Chine] ; Guoyuan Zhang ; Xiaolan Guo | A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays. |
| 000A34 (2020) |
Meng Yuan [États-Unis] ; Nicholas C. Wu [États-Unis] ; Xueyong Zhu [États-Unis] ; Chang-Chun D. Lee [États-Unis] ; Ray T. Y. So [République populaire de Chine] ; Huibin Lv [République populaire de Chine] ; Chris K. P. Mok [République populaire de Chine] ; Ian A. Wilson [États-Unis] | A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV |
| 000A77 (2009) |
Xin Chen [Taïwan] ; Chi-Yuan Chou ; Gu-Gang Chang | Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme. |
| 000A98 (2004) |
Paul K. S. Chan [République populaire de Chine, Hong Kong] ; W. K. To [République populaire de Chine] ; Esther Y. M. Liu [République populaire de Chine] ; T. K. Ng [République populaire de Chine] ; John S. Tam [République populaire de Chine] ; Joseph J. Y. Sung [République populaire de Chine] ; Jean-Michel Lacroix [Canada] ; Michel Houde [Canada] | Evaluation of a peptide‐based enzyme immunoassay for anti‐SARS coronavirus IgG antibody |
| 000A99 (2004) |
Hans Jürgen Rösner [Allemagne] | China's health insurance system in transformation: Preliminary assessment, and policy suggestions |
